EP Finance has acquired Creapharm. This acquisition is intended to link the clinical supplies activities of EP’s subsidiary Sodia in Reims, France with those of Creapharm in Bordeaux. The companies provide production, packaging, distribution and expertise for pharmaceuticals. “Synergies between both sites will be progressively activated in order to further enhance reactivity and flexibility to meet the requests of new and existing clients, while maintaining the highest regulatory an...